{
    "clinical_study": {
        "@rank": "62303", 
        "brief_summary": {
            "textblock": "RATIONALE: Interferon alfa may interfere with the growth of the cancer cells and slow the\n      growth of kidney cancer. Isotretinoin may help kidney cancer cells develop into normal\n      cells. It is not yet known whether interferon alfa plus isotretinoin is more effective than\n      interferon alfa alone for kidney cancer.\n\n      PURPOSE: Randomized phase III trial to compare the effectiveness of interferon alfa with or\n      without isotretinoin in treating patients who have metastatic kidney cancer."
        }, 
        "brief_title": "Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer", 
        "condition": "Kidney Cancer", 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma, Renal Cell", 
                "Kidney Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES: I. Assess the response rate and response duration of interferon alfa with vs\n      without isotretinoin in patients with bidimensionally measurable progressive metastases from\n      renal cell cancer. II. Assess the toxic effects of these regimens in this patients\n      population. III. Determine the overall survival of this patient population treated with\n      these regimens.\n\n      OUTLINE: This is a randomized, multicenter study. Patients are stratified according to\n      participating center. Patients are randomized to one of two treatment arms. Arm I: Patients\n      receive interferon alfa subcutaneously daily. Arm II: Patients receive interferon alfa as in\n      arm I plus oral isotretinoin daily. Treatment continues for up to 1 year in the absence of\n      disease progression or unacceptable toxicity. Patients are followed until death.\n\n      PROJECTED ACCRUAL: A total of 296 patients will be accrued for this study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS: Histologically confirmed metastatic renal cell adenocarcinoma\n        Histologic confirmation of metastases desirable Progression of metastases within 2 months\n        of study No clinically manifest CNS metastasis Bidimensionally measurable metastases, as\n        follows: Lung lesion with diameter greater than 2 cm Superficial lymph node or skin or\n        subcutaneous lesion with diameter greater than 2.5 cm Lymph node in the mediastinum or\n        retroperitoneal region, liver lesion, or soft tissue lesion visible on CT or ultrasound\n        with initial diameter greater than 2.5 cm No bone lesion without surrounding, measurable\n        soft tissue lesion\n\n        PATIENT CHARACTERISTICS: Age: 18 to 75 Performance status: WHO 0 or 1 Life expectancy: At\n        least 90 days Hematopoietic: WBC greater than 3,000/mm3 OR Absolute granulocyte count\n        greater than 1,500/mm3 OR Platelet count greater than 100,000/mm3 Hepatic: Bilirubin no\n        greater than 1.1 mg/dL Lipids no greater than 1.5 times normal Renal: Creatinine no\n        greater than 1.6 mg/dL Cardiovascular: No congestive heart failure No significant\n        arrhythmia No complete bundle branch block Pulmonary: No serious concurrent pulmonary\n        illness Other: No recent uncontrolled bleeding No serous effusion No history of autoimmune\n        disease No controlled or uncontrolled active infection No seizure disorder or compromised\n        CNS function No secondary gastrointestinal dysfunction that could interfere with drug\n        absorption No psychological condition that would preclude participation or consent No\n        second malignancy except basal cell skin cancer or carcinoma in situ of the cervix Not\n        pregnant or nursing Fertile patients must use effective contraception\n\n        PRIOR CONCURRENT THERAPY: Biologic therapy: No prior immunotherapy Chemotherapy: No prior\n        chemotherapy Endocrine therapy: No concurrent hormonal therapy Radiotherapy: At least 3\n        months since irradiation of target lesions Subsequent progression or new lesion required\n        No concurrent radiotherapy Surgery: Prior nephrectomy required No concurrent surgery\n        Other: No concurrent tetracyclines or hepatotoxic drugs"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "320", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 1, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002737", 
            "org_study_id": "EORTC-30951", 
            "secondary_id": "EORTC-30951"
        }, 
        "intervention": [
            {
                "intervention_name": "recombinant interferon alfa", 
                "intervention_type": "Biological"
            }, 
            {
                "intervention_name": "chemotherapy", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "isotretinoin", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Interferon-alpha", 
                "Interferon Alfa-2a", 
                "Interferons", 
                "Isotretinoin"
            ]
        }, 
        "keyword": [
            "stage IV renal cell cancer", 
            "recurrent renal cell cancer"
        ], 
        "lastchanged_date": "July 10, 2012", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/EORTC-30951"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Aalst", 
                        "country": "Belgium", 
                        "zip": "B-9300"
                    }, 
                    "name": "Onze Lieve Vrouw Ziekenhuis Aalst"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Antwerp", 
                        "country": "Belgium", 
                        "zip": "2020"
                    }, 
                    "name": "Algemeen Ziekenhuis Middelheim"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brussels", 
                        "country": "Belgium", 
                        "zip": "1000"
                    }, 
                    "name": "Institut Jules Bordet"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Edegem", 
                        "country": "Belgium", 
                        "zip": "B-2650"
                    }, 
                    "name": "Universitair Ziekenhuis Antwerpen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leuven", 
                        "country": "Belgium", 
                        "zip": "B-3000"
                    }, 
                    "name": "U.Z. Gasthuisberg"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Budapest", 
                        "country": "Hungary", 
                        "zip": "1125"
                    }, 
                    "name": "National Institute of Oncology"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Varese", 
                        "country": "Italy", 
                        "zip": "21100"
                    }, 
                    "name": "Ospedale di Circolo e Fondazione Macchi"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "zip": "1105 AZ"
                    }, 
                    "name": "Academisch Medisch Centrum"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "zip": "1066 CX"
                    }, 
                    "name": "Antoni van Leeuwenhoekhuis"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hertogenbosch", 
                        "country": "Netherlands", 
                        "zip": "5211 NL"
                    }, 
                    "name": "Groot Ziekengasthuis 's-Hertogenbosch"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leiden", 
                        "country": "Netherlands", 
                        "zip": "2300 CA"
                    }, 
                    "name": "Leiden University Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nijmegen", 
                        "country": "Netherlands", 
                        "zip": "NL-6252 HB"
                    }, 
                    "name": "University Medical Center Nijmegen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rotterdam", 
                        "country": "Netherlands", 
                        "zip": "3075 EA"
                    }, 
                    "name": "Rotterdam Cancer Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rotterdam", 
                        "country": "Netherlands", 
                        "zip": "3000 CA"
                    }, 
                    "name": "University Hospital - Rotterdam Dijkzigt"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Utrecht", 
                        "country": "Netherlands", 
                        "zip": "3508 GA"
                    }, 
                    "name": "Academisch Ziekenhuis Utrecht"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oslo", 
                        "country": "Norway", 
                        "zip": "N-0310"
                    }, 
                    "name": "Norwegian Radium Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Moscow", 
                        "country": "Russian Federation", 
                        "zip": "115478"
                    }, 
                    "name": "Russian Academy of Medical Sciences Cancer Research Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Aarau", 
                        "country": "Switzerland", 
                        "zip": "5001"
                    }, 
                    "name": "Kantonspital Aarau"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bellinzona", 
                        "country": "Switzerland", 
                        "zip": "CH-6500"
                    }, 
                    "name": "Ospedale San Giovanni"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bern", 
                        "country": "Switzerland", 
                        "zip": "CH-3010"
                    }, 
                    "name": "Inselspital, Bern"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chur", 
                        "country": "Switzerland", 
                        "zip": "CH-7000"
                    }, 
                    "name": "Ratisches Kantons und Regionalspital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lausanne", 
                        "country": "Switzerland", 
                        "zip": "CH-1011"
                    }, 
                    "name": "Centre Hospitalier Universitaire Vaudois"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint Gallen", 
                        "country": "Switzerland", 
                        "zip": "CH-9007"
                    }, 
                    "name": "Kantonsspital - Saint Gallen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zurich", 
                        "country": "Switzerland", 
                        "zip": "CH-8091"
                    }, 
                    "name": "Universitaetsspital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Istanbul", 
                        "country": "Turkey", 
                        "zip": "81190"
                    }, 
                    "name": "Marmara University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bristol", 
                        "country": "United Kingdom", 
                        "state": "England", 
                        "zip": "BS2 8HW"
                    }, 
                    "name": "Bristol Royal Infirmary"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Glasgow", 
                        "country": "United Kingdom", 
                        "state": "Scotland", 
                        "zip": "G11 6NT"
                    }, 
                    "name": "Beatson Oncology Centre"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "Hungary", 
                "Italy", 
                "Netherlands", 
                "Norway", 
                "Russian Federation", 
                "Switzerland", 
                "Turkey", 
                "United Kingdom"
            ]
        }, 
        "official_title": "A RANDOMIZED PHASE II TRIAL OF INTERFERON ALPHA-2A WITH AND WITHOUT 13-CIS RETINOIC ACID IN PATIENTS WITH PROGRESSIVE MEASURABLE METASTATIC RENAL CELL CARCINOMA. Amendment Protocol: Extension to a Randomized Phase III Trial", 
        "overall_official": {
            "affiliation": "Norwegian Radium Hospital", 
            "last_name": "Nina Aass, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "January 2001", 
            "@type": "Actual"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002737"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": {
            "PMID": "15961764", 
            "citation": "Aass N, De Mulder PH, Mickisch GH, Mulders P, van Oosterom AT, van Poppel H, Fossa SD, de Prijck L, Sylvester RJ. Randomized phase II/III trial of interferon Alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell Carcinoma: the European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951). J Clin Oncol. 2005 Jun 20;23(18):4172-8."
        }, 
        "source": "European Organisation for Research and Treatment of Cancer - EORTC", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "European Organisation for Research and Treatment of Cancer - EORTC", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 1996", 
        "study_design": "Allocation: Randomized, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2012"
    }, 
    "geocoordinates": {
        "Academisch Medisch Centrum": "52.37 4.895", 
        "Academisch Ziekenhuis Utrecht": "52.09 5.11", 
        "Algemeen Ziekenhuis Middelheim": "51.219 4.403", 
        "Antoni van Leeuwenhoekhuis": "52.37 4.895", 
        "Beatson Oncology Centre": "55.864 -4.252", 
        "Bristol Royal Infirmary": "51.455 -2.588", 
        "Centre Hospitalier Universitaire Vaudois": "46.52 6.634", 
        "Groot Ziekengasthuis 's-Hertogenbosch": "51.698 5.317", 
        "Inselspital, Bern": "46.948 7.445", 
        "Institut Jules Bordet": "50.85 4.352", 
        "Kantonspital Aarau": "47.391 8.046", 
        "Kantonsspital - Saint Gallen": "47.424 9.371", 
        "Leiden University Medical Center": "52.16 4.494", 
        "Marmara University Hospital": "41.005 28.977", 
        "National Institute of Oncology": "47.498 19.041", 
        "Norwegian Radium Hospital": "59.914 10.752", 
        "Onze Lieve Vrouw Ziekenhuis Aalst": "50.938 4.041", 
        "Ospedale San Giovanni": "46.198 9.027", 
        "Ospedale di Circolo e Fondazione Macchi": "45.818 8.826", 
        "Ratisches Kantons und Regionalspital": "46.857 9.527", 
        "Rotterdam Cancer Institute": "51.924 4.482", 
        "Russian Academy of Medical Sciences Cancer Research Center": "55.75 37.617", 
        "U.Z. Gasthuisberg": "50.878 4.704", 
        "Universitaetsspital": "47.369 8.539", 
        "Universitair Ziekenhuis Antwerpen": "51.153 4.438", 
        "University Hospital - Rotterdam Dijkzigt": "51.924 4.482", 
        "University Medical Center Nijmegen": "51.843 5.855"
    }
}